Company & Sponsor Intelligence

Assaf-Harofeh Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting1

Completed1

Countries1

Therapeutic footprint

adhdautism

Indexed studies

NCT04054934Influence of Circadian Clock on Hormonal, Metabolic, Neurocognitive Markers in Adolescents With and Without Diabetes
adhd · NOT_YET_RECRUITING

NCT05212493The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder
autism · IsraelPHASE3

NCT01393574Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties
adhd · IsraelPHASE4

Intelligence layer updated: 2026-10-20 06:14:04.499488+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →